Healthnostics Reports Continued GMD Record Growth Pace into First Quarter 2009

Business Wire, Sept 23, 2008

-GMD, A National Consumer Diabetic Supply and Education Services Company Strongly Increases Gross Margins to 43%-

NEW YORK -- Healthnostics, Inc. (OTC: HNSO), a medical and biotechnology information and technology company, is pleased to provide this mid-quarter update on GMD's first fiscal quarter for the year ending June 30, 2009. Net revenue for July and August, 2008 were $2.2 million on a profitable basis. This compares to revenue of $1.38 million for the same two month period in fiscal year 2008, which is an increase of over $800,000. Gross margins strongly increased to a sustainable 43% from 32% for the same periods in fiscal year 2007.

This strong increase is attributed to the success of GMD's new marketing strategy previously announced coupled with a phasing out of an underperforming contract.

"GMD set company records in fiscal year 2008 and is well on its way to doing the same in 2009," said Alan Grofe, President of Healthnostics and CEO of GMD, Inc. "GMD has a proven track record of providing clients with quality diabetic products and service that puts GMD in a very favorable position to further accelerate growth through this new year."

About GMD, Inc.

Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients lead healthier and more productive lives. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetes maintenance medications, diabetic shoes and orthopedic inserts.

For further information please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, MedNets www.mednets.com, and FamilyMedicalNet www.familymedicalnet.com.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.